Indication
Substance Use Disorder in Pregnancy
3 clinical trials
1 product
Clinical trial
NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a Pragmatic Randomized Trial Comparing Extended-release and Daily Buprenorphine Formulations: Conceptual Model Assessments (CMA) Sub-studyStatus: Active (not recruiting), Estimated PCD: 2025-01-31
Product
BuprenorphineClinical trial
Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a Pragmatic Randomized Trial Comparing Extended-release and Daily Buprenorphine FormulationsStatus: Active (not recruiting), Estimated PCD: 2025-01-31
Clinical trial
NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): Infant Neurodevelopmental Outcomes (INO) Sub-studyStatus: Recruiting, Estimated PCD: 2025-01-31